English  |  正體中文  |  简体中文  |  總筆數 :2856704  
造訪人次 :  53638407    線上人數 :  2190
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsieh m s"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 101-150 / 306 (共7頁)
<< < 1 2 3 4 5 6 7 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-05-21T07:17:43Z Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment Lu S.-L.; Hsu F.-M.; CHIAO-LING TSAI; Lee J.-M.; Huang P.-M.; Hsu C.-H.; Lin C.-C.; Chang Y.-L.; Hsieh M.-S.; Cheng J.C.-H.
臺大學術典藏 2021-04-29T05:08:56Z Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer Chen C.-Y.; Chen Y.-Y.; Hsieh M.-S.; Ho C.-C.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:55Z Coexistence of the BRAF Mutation and EGFR Exon 20?Insertion in a Patient with Lung Adenocarcinoma Chang L.-C.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J.; Hsieh M.-S.
臺大學術典藏 2021-04-27T08:36:01Z Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; HUNG-YANG KUO; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H.
臺大學術典藏 2021-04-27T08:11:50Z Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; HUNG-YANG KUO; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H.
臺大學術典藏 2021-03-19T06:57:29Z Preoperative computed tomography-guided dye injection to localize multiple lung nodules for video-assisted thoracoscopic surgery Tseng Y.-H.; Lee Y.-F.; Hsieh M.-S.; Chien N.; Ko W.-C.; Chen J.-Y.; Lee J.-M.; Huang P.-M.; Lin M.-W.; Chen J.-S.; YEUN-CHUNG CHANG
臺大學術典藏 2021-03-19T06:57:24Z Computed tomography-guided patent blue vital dye localization of pulmonary nodules in uniportal thoracoscopy Lin M.-W.; Tseng Y.-H.; Lee Y.-F.; Hsieh M.-S.; Ko W.-C.; Chen J.-Y.; Hsu H.-H.; YEUN-CHUNG CHANG; Chen J.-S.
臺大學術典藏 2021-03-19T06:57:20Z Extraction of radiomic values from lung adenocarcinoma with near-pure subtypes in the International Association for the Study of Lung Cancer/the American Thoracic Society/the European Respiratory Society (IASLC/ATS/ERS) classification Yang S.-M.;Chen L.-W.;Wang H.-J.;Chen L.-R.;Lor K.-L.;Chen Y.-C.;Lin M.-W.;Hsieh M.-S.;Chen J.-S.;Yeun-Chung Chang;Chen C.-M.; Yang S.-M.; Chen L.-W.; Wang H.-J.; Chen L.-R.; Lor K.-L.; Chen Y.-C.; Lin M.-W.; Hsieh M.-S.; Chen J.-S.; YEUN-CHUNG CHANG; Chen C.-M.
臺大學術典藏 2021-03-19T06:57:14Z Prediction of micropapillary and solid pattern in lung adenocarcinoma using radiomic values extracted from near-pure histopathological subtypes Chen L.-W.; Yang S.-M.; Wang H.-J.; Chen Y.-C.; Lin M.-W.; Hsieh M.-S.; Song H.-L.; Ko H.-J.; Chen C.-M.; YEUN-CHUNG CHANG
臺大學術典藏 2021-03-18T02:02:58Z Combined Pancreatic Endocrine Tumor and Serous Cystadenoma Hsieh M.-S.; Liu K.-L.; Tien Y.-W.; CHIA-TUNG SHUN
臺大學術典藏 2021-03-18T02:02:57Z Hepatic Epithelioid Hemangioendothelioma in Taiwan: A Clinicopathologic Study of Six Cases in a Single Institution Over a 15-Year Period Hsieh M.-S.;Liang P.-C.;Kao Y.-C.;Chia-Tung Shun; Hsieh M.-S.; Liang P.-C.; Kao Y.-C.; CHIA-TUNG SHUN
臺大學術典藏 2021-03-15T07:44:48Z �]-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma LI-CHUN LU; Shao Y.-Y.; Lee Y.-H.; Hsieh M.-S.; Hsiao C.-H.; Lin H.-H.; Kao H.-F.; Ma Y.-Y.; Yen F.-C.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-03-13T03:29:30Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations YEN-FU CHEN; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏 2021-03-13T03:29:28Z Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations YEN-FU CHEN; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2021-03-11T08:34:21Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih
臺大學術典藏 2021-03-11T08:29:35Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T07:58:31Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-10T05:34:19Z Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma Guo J.-C.; Ta-Chen Huang; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; Yeh K.-H.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-03-10T05:34:17Z Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; Shao Y.-Y.; Ta-Chen Huang; Hsu C.-H.
臺大學術典藏 2021-03-05T08:19:31Z Precancerous esophageal epithelia are associated with significantly increased scattering coefficients Su J.-W.; Lin Y.-H.; Chiang C.-P.; Lee J.-M.; Hsieh C.-M.; Hsieh M.-S.; Yang P.-W.; Wang C.-P.; PING-HUEI TSENG; Lee Y.-C.; Sung K.-B.
臺大學術典藏 2021-02-26T01:59:42Z Mycobacterium tuberculosis and non-tuberculous mycobacterium infections in hematological patients with febrile neutropenia Chen C.-Y.;Hsieh M.-S.;Wang-Huei Sheng; Chen C.-Y.; Hsieh M.-S.; WANG-HUEI SHENG
臺大學術典藏 2021-02-02T05:45:23Z Precancerous esophageal epithelia are associated with significantly increased scattering coefficients Su J.-W.;Lin Y.-H.;Chiang C.-P.;Lee J.-M.;Hsieh C.-M.;Hsieh M.-S.;Yang P.-W.;Wang C.-P.;Tseng P.-H.;Yi-Chia Lee;Sung K.-B.; Su J.-W.; Lin Y.-H.; Chiang C.-P.; Lee J.-M.; Hsieh C.-M.; Hsieh M.-S.; Yang P.-W.; Wang C.-P.; Tseng P.-H.; YI-CHIA LEE; Sung K.-B.
臺大學術典藏 2021-01-28T01:06:28Z Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma Guo J.-C.;Huang T.-C.;Lin C.-C.;Hsieh M.-S.;Chang C.-H.;Huang P.-M.;Lee J.-M.;Hsu F.-M.;Cheng J.C.-H.;Wang H.-P.;Kun-Huei Yeh;Cheng A.-L.;Hsu C.-H.; Guo J.-C.; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; KUN-HUEI YEH; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-01-15T03:46:41Z Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma Guo J.-C.; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; HSIU-PO WANG; Yeh K.-H.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-01-08T03:40:20Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Shih J.-Y.; Ko J.-C.; Lee M.-R.; Keng L.-T.; Hsieh M.-S.; SHENG-KAI LIANG
臺大學術典藏 2021-01-08T02:56:48Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Li-Ta Keng;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Hsieh M.-S.; Lee M.-R.; LI-TA KENG; Ko J.-C.; Shih J.-Y.
臺大學術典藏 2021-01-04T12:12:27Z Overexpression of FLT3-ITD driven by spi-1 results in expanded myelopoiesis with leukemic phenotype in zebrafish Lin L.-I.; HWEI-FANG TIEN; Hou H.-A.; Hsieh M.-S.; Lu J.-W.
臺大學術典藏 2020-12-02T02:33:45Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Chang Y.-L.;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tsai T.-H.;Yu C.-J.;Yang J.C.-H.;PAN-CHYR YANG; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:33:26Z Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Pan-Chyr Yang; Shih J.-Y.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏 2020-12-02T02:33:03Z Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression Chen Y.-J.; Roumeliotis T.I.; Chang Y.-H.; Chen C.-T.; Han C.-L.; Lin M.-H.; Chen H.-W.; Chang G.-C.; Chang Y.-L.; Wu C.-T.; Lin M.-W.; Hsieh M.-S.; Wang Y.-T.; Chen Y.-R.; Jonassen I.; Ghavidel F.Z.; Lin Z.-S.; Lin K.-T.; Chen C.-W.; Sheu P.-Y.; Hung C.-T.; Huang K.-C.; Yang H.-C.; Lin P.-Y.; Yen T.-C.; Lin Y.-W.; Wang J.-H.; Raghav L.; Lin C.-Y.; Chen Y.-S.; Wu P.-S.; Lai C.-T.; Weng S.-H.; Su K.-Y.; Chang W.-H.; Tsai P.-Y.; Robles A.I.; Rodriguez H.; Hsiao Y.-J.; Chang W.-H.; Sung T.-Y.; Chen J.-S.; Yu S.-L.; Choudhary J.S.; Chen H.-Y.; PAN-CHYR YANG; Chen Y.-J.
臺大學術典藏 2020-10-22T07:27:42Z Thymoma-associated multiorgan autoimmunity Hung C.-T.;Tsen-Fang Tsai;Chen J.-S.;Hsieh M.-S.; Hung C.-T.; TSEN-FANG TSAI; Chen J.-S.; Hsieh M.-S.
臺大學術典藏 2020-09-30T05:57:44Z Correlation of tumor spread through air spaces and clinicopathological characteristics in surgically resected lung adenocarcinomas Chen J.-S.; Hu S.-Y.; Hsieh M.-S.; Hsu H.-H.; Tsai T.-M.; Chiang X.-H.; Tsou K.-C.; HSIEN-CHI LIAO; Lin M.-W.
臺大學術典藏 2020-09-30T05:57:43Z Corrigendum to “Correlation of tumor spread through air spaces and clinicopathological characteristics in surgically resected lung adenocarcinomas” [Lung Cancer 126 (2018) 189–193](S0169500218306305)(10.1016/j.lungcan.2018.11.003) Hu S.-Y.; Hsieh M.-S.; Hsu H.-H.; Tsai T.-M.; Chiang X.-H.; Tsou K.-C.; HSIEN-CHI LIAO; Lin M.-W.; Chen J.-S.
臺大學術典藏 2020-09-29T06:53:01Z Ultrasonographic features for differentiating follicular thyroid carcinoma and follicular adenoma Chen C.-N.; Chen A.; TING-CHUN KUO; Wu M.-H.; Chen K.-Y.; Hsieh M.-S.
臺大學術典藏 2020-09-23T02:17:00Z Preoperative computed tomography-guided dye injection to localize multiple lung nodules for video-assisted thoracoscopic surgery Chang Y.-C.; Chen J.-S.; Lin M.-W.; Huang P.-M.; Lee J.-M.; Chen J.-Y.; Ko W.-C.; NING CHIEN; Hsieh M.-S.; Lee Y.-F.; Tseng Y.-H.
臺大學術典藏 2020-09-22T07:00:26Z Preoperative computed tomography-guided dye injection to localize multiple lung nodules for video-assisted thoracoscopic surgery Lee J.-M.; Huang P.-M.; Lin M.-W.; Chen J.-S.; Chang Y.-C.; Chen J.-Y.; Ko W.-C.; Tseng Y.-H.; YEE-FAN LEE; Hsieh M.-S.; Chien N.
臺大學術典藏 2020-09-22T07:00:25Z Computed tomography-guided patent blue vital dye localization of pulmonary nodules in uniportal thoracoscopy Lin M.-W.; Tseng Y.-H.; YEE-FAN LEE; Hsieh M.-S.; Ko W.-C.; Chen J.-Y.; Hsu H.-H.; Chang Y.-C.; Chen J.-S.
臺大學術典藏 2020-08-14T08:39:03Z Preoperative computed tomography-guided dye injection to localize multiple lung nodules for video-assisted thoracoscopic surgery Lin M.-W.; Huang P.-M.; Tseng Y.-H.; Lee Y.-F.; Hsieh M.-S.; Chien N.; Ko W.-C.; JO-YU CHEN; Lee J.-M.; Chang Y.-C.; Chen J.-S.
臺大學術典藏 2020-08-14T08:39:02Z Computed tomography-guided patent blue vital dye localization of pulmonary nodules in uniportal thoracoscopy Lin M.-W.; Tseng Y.-H.; Lee Y.-F.; Hsieh M.-S.; Ko W.-C.; JO-YU CHEN; Hsu H.-H.; Chang Y.-C.; Chen J.-S.
臺大學術典藏 2020-08-13T06:33:46Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; JIN-YUAN SHIH; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:39Z Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; JIN-YUAN SHIH
臺大學術典藏 2020-08-13T06:33:37Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Ko J.-C.;Jin-Yuan Shih; Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; Ko J.-C.; JIN-YUAN SHIH
臺大學術典藏 2020-08-13T06:33:33Z Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study Yang J.C.-H.; Thress K.S.; Huang D.D.-R.; Bai Y.-Y.; Chang Y.-L.; Hsieh M.-S.; Su K.-Y.; Tsai T.-H.; Lee J.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; JIN-YUAN SHIH; Yu C.-J.; Lin C.-C.;Jin-Yuan Shih;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.
臺大學術典藏 2020-08-13T06:33:30Z Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer JIN-YUAN SHIH; Gow C.-H.;Liu Y.-N.;Li H.-Y.;Hsieh M.-S.;Chang S.-H.;Luo S.-C.;Tsai T.-H.;Chen P.-L.;Tsai M.-F.;Jin-Yuan Shih; Gow C.-H.; Liu Y.-N.; Li H.-Y.; Hsieh M.-S.; Chang S.-H.; Luo S.-C.; Tsai T.-H.; Chen P.-L.; Tsai M.-F.
臺大學術典藏 2020-08-13T06:33:28Z Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinoma Yang C.-Y.; Hsieh M.-S.; Liao W.-Y.; JIN-YUAN SHIH; Yu C.-J.
臺大學術典藏 2020-08-13T06:33:27Z Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas Gow C.-H.; Hsieh M.-S.; Lin Y.-T.; Liu Y.-N.; JIN-YUAN SHIH
臺大學術典藏 2020-08-12T08:25:25Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; SHANG-GIN WU; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.
臺大學術典藏 2020-08-12T08:25:23Z Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations Chen Y.-F.; Hsieh M.-S.; SHANG-GIN WU; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Shih J.-Y.; Chen Y.-F.;Hsieh M.-S.;Shang-Gin Wu;Chang Y.-L.;Yu C.-J.;Yang J.C.-H.;Yang P.-C.;Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:23Z Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion Tsai T.-H.;Shang-Gin Wu;Hsieh M.-S.;Yu C.-J.;Yang J.C.H.;Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Hsieh M.-S.; Yu C.-J.; Yang J.C.H.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:21Z A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population Gow C.-H.; Hsieh M.-S.; SHANG-GIN WU; Shih J.-Y.

顯示項目 101-150 / 306 (共7頁)
<< < 1 2 3 4 5 6 7 > >>
每頁顯示[10|25|50]項目